Industry Updates for the Psychedelics World

Psychedelics News

Industry

31 Jan 2023

Origin Signs Letter of Intent to Acquire Safe Supply Streaming

Origin Enters into Binding Letter of Intent with Safe Supply Streaming Co....

By Microdose NewsDesk

Industry

27 Jan 2023

Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific

Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific...

By Microdose NewsDesk

Industry

25 Jan 2023

Small Pharma DMT Depression Trial: 57% of Patients Enter Remission

Small Pharma Phase 2a trial results....

By James Hallifax

Industry

25 Jan 2023

Small Pharma Reports Positive Results from Phase IIa DMT Trial

Big news as Small Pharma has announced positive topline results for its Phase 2a trial using DMT for depression....

By Microdose NewsDesk

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

20 Jan 2023

Mindset Granted Patent for Lead Drug (But Reunion Also Has Patent)

Mindset Pharma has been granted a U....

By Microdose NewsDesk

Industry

18 Jan 2023

Cybin Announces Promising Results From Study Measuring Psychedelic Effects on the Brain

Cybin Announces Promising Results from Kernel Flow® Study Measuring Psychedelic Effects on the Brain...

By Microdose NewsDesk

Industry

18 Jan 2023

Microdosing DMT to Treat Strokes: Not as Trippy as it Sounds

On January 17th, the company Algernon Pharmaceuticals announced that they had dosed the first patient in their Phase 1 safety trial of the psychedelic drug DMT to treat stroke patients....

By James Hallifax

Industry

17 Jan 2023

Algernon NeuroScience Doses First Subject in Phase 1 DMT Clinical Stroke Study

Algernon Pharmaceuticals subsidiary, Algernon NeuroScience, has dosed the first subject in its Phase 1 clinical study of an intravenous formulation of DMT in the Netherlands....

By Microdose NewsDesk

Industry

12 Jan 2023

Cybin Selects Generalized Anxiety Disorder for DMT Drug CYB-004

Cybin has selected Generalized Anxiety Disorder as the target indication for its proprietary deuterated N, N-dimethyltryptamine DMT program CYB004....

By Microdose NewsDesk

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result